DermSpectra™ to Conduct Collaborative Research with Mayo Clinic on Automated Total Body Digital Skin Imaging
Posted on December 16, 2014 by DermSpectra™
TUCSON, Arizona – DermSpectra’s Total Body Digital Skin Imaging System will be studied at Mayo Clinic to collect and analyze patient and dermatologists’ perceptions of the impact of digital skin imaging in skin documentation and medical decision making, as well as their experiences using the system.
DermSpectra™ Total Body Digital Skin Imaging System enables physicians to monitor critical skin changes over time (including benign and malignant lesions, and inflammatory conditions such as eczema, psoriasis, and skin eruptions) to ensure the most accurate medical assessment and health outcomes for patients. The advanced medical technology modernizes the way physicians visually capture and compare skin changes by rapidly providing objective, high-definition images to aid in the early detection of skin cancers and other skin conditions.
James Yiannias, M.D., dermatologist and associate medical director of the Mayo Clinic Center for Innovation is the principal investigator of the pilot research.
“Mayo Clinic’s Center for Innovation is collaborating with us to assess the patient experience and to help guide improvements on the operation of the DermSpectra digital imaging system to further enhance patient care,” said Karleen Seybold, chief executive officer of DermSpectra.
“We are excited to have this study done at Mayo Clinic, given the high incidence of skin disease in Arizona,” said Richard Carmona, M.D., 17th U.S. Surgeon General and DermSpectra board member. “We look forward to further advancing precision medicine in a field that could greatly benefit from standardized high-resolution imaging acquisition, secured data storage, efficient delivery of images, and an intuitive interface for the medical providers and the patients. In addition, with the number of skin cancers increasing to more than an astounding 4.9 million cases treated a year, it is crucial for physicians to have an effective tool to optimize skin surveillance and lesion monitoring in order to aid in early detection of skin diseases.”
DermSpectra™, based in Tucson, Arizona, is a solutions-oriented medical device company founded by Principal Karleen Seybold. The DermSpectra™ Total Body Digital Skin Imaging System is a proprietary solution that delivers patented high-resolution imaging, secure storage, and immediate viewing capabilities. With the most advanced level of precision in the market, DermSpectra sets the industry standard (definition, timing, lighting, image quality, data formats, storage, and interfaces) in digital skin imaging. DermSpectra units have been installed in well-known medical and research centers around the country. For more information, call 1-800-610-2079 or visit www.dermspectra.com